Diagnostics antibodies and antigens for cardiovascular diseases biomarkers testing

Cardiovascular diseases are a group of disorders that occur in the heart and blood vessels and are the world’s leading cause of death. In vitro Diagnostics (IVD) assays for detecting cardiac markers are essential tools to help treat or prevent CVD. Several protein markers are released into the blood when the heart is damaged or stressed. These protein markers support diagnosis of conditions including coronary heart disease, cerebrovascular disease, and deep vein thrombosis to guide therapeutic intervention. Several cardiovascular diseases such as hypertension, coronary artery stenosis, intrinsic cardiac dysfunction, acute ischemic myocardial injury, acute myocardial infarction, angiogenesis, artery lesions, atherosclerosis, blood pressure, congestive heart failure, Deep vein thrombosis (DVT), heart failure, hypertrophic cardiomyopathy, myocardial infarction, renal artery stenosis, restrictive and dilated cardiomyopathy, vascular inflammation and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.

Classification: MPO MMP3 GDF-15 CK-MB Myo sST2 CKMB NT-proBNP cTnT cTnI H-FABP D-Dimer Dig ApoA ApoE BNP proBNP TIMP-1 CNP ANP AI VEGF PLGF-1 SAH HCY RAA/Aldo Digoxin HFABP DCT ADP SDN